← Leaderboards
Arupa Ganguly
University Of Pennsylvania
$6,511,479
Attributed
$8,820,091
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2007–24$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,820,091 · 4
By mechanism
R01$8,085,092 · 2
R21$734,999 · 2
Top collaborators
- Diva Del Carmen De Leon7 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Frank J. Rauscher$12,105,145
- Laurence A Turka$19,677,777
- Klaus H. Kaestner$80,959,526
- David L Gasser$5,974,420
- Wade H Berrettini$18,086,963
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadGenesMutationGenomicsMolecularInfantGenotypeChildAffectBloodVariantPathway InteractionsChildhoodFamilyBilateralMalignant NeoplasmsInstitutionAdultRb1 GeneFamily History OfNew Therapeutic TargetExome SequencingEtiologyEvaluation
Grant awards (17)
Islet Dysregulation in Infants with Congenital Hyperinsulinism$628,722
R01 · FY2024 · DK
Islet Dysregulation in Infants with Congenital Hyperinsulinism$694,490
R01 · FY2023 · DK
Islet Dysregulation in Infants with Congenital Hyperinsulinism$928,666
R01 · FY2022 · DK
Islet Dysregulation in Infants with Congenital Hyperinsulinism$737,330
R01 · FY2021 · DK
Neurological Phenotyping in Hyperinsulinism â Administrative Supplement to Islet dysregulation in Infants with Congenital Hyperinsulinism$203,709
R01 · FY2021 · DK
Islet Dysregulation in Infants with Congenital Hyperinsulinism$748,419
R01 · FY2020 · DK
Islet Dysregulation in Infants with Congenital Hyperinsulinism$675,889
R01 · FY2018 · DK
Mutation Profile as Translatable Prognostic Biomarker of Uveal Melanoma$174,000
R21 · FY2016 · CA · contact PI
Mutation Profile as Translatable Prognostic Biomarker of Uveal Melanoma$208,800
R21 · FY2015 · CA · contact PI
Parental genotypes and exposures in sporadic retinoblastoma$537,579
R01 · FY2011 · CA · contact PI
Parental genotypes and exposures in sporadic retinoblastoma$582,164
R01 · FY2010 · CA · contact PI
Parental genotypes and exposures in sporadic retinoblastoma$588,582
R01 · FY2009 · CA · contact PI
Parental genotypes and exposures in sporadic retinoblastoma$583,922
R01 · FY2009 · CA · contact PI
Parental genotypes and exposures in sporadic retinoblastoma$567,617
R01 · FY2008 · CA · contact PI
Application of genomic approaches to classify retinoblastoma tumors$161,650
R21 · FY2008 · CA · contact PI
Parental genotypes and exposures in sporadic retinoblastoma$608,003
R01 · FY2007 · CA · contact PI
Application of genomic approaches to classify retinoblastoma tumors$190,549
R21 · FY2007 · CA · contact PI